Jaan-Olle Andressoo

Prof. Jaan-Olle Andressoo

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2002 in Science
Verified
Journal Article
Closed access
PDF file
JBJan de Boer
Jan de Boer
Jaan-Olle AndressooJaan-Olle Andressoo
Jaan-Olle Andressoo
JWJan de Wit
Jan de Wit
JHJan Huijmans
Jan Huijmans
RBRudolph B. Beems
Rudolph B. Beems
JHJan H. J. Hoeijmakers
Jan H. J. Hoeijmakers
One of the factors postulated to drive the aging process is the accumulation of DNA damage. Here, we provide strong support for this hypothesis by describing studies of mice with a mutation in XPD , a gene encoding a DNA helicase that functions in both repair and transcription and that is mutated in the human disorder trichothiodystrophy (TTD). TTD mice were found to exhibit many symptoms of premature aging, including osteoporosis and kyphosis, osteosclerosis, early greying, cachexia, infertility, and reduced life-span. TTD mice carrying an additional mutation in XPA , which enhances the DNA repair defect, showed a greatly accelerated aging phenotype, which correlated with an increased cellular sensitivity to oxidative DNA damage. We hypothesize that aging in TTD mice is caused by unrepaired DNA damage that compromises transcription, leading to functional inactivation of critical genes and enhanced apoptosis.

1 July 2007 in Nature
Verified
Journal Article
Closed access
PLPäivi Lindholm
Päivi Lindholm
MVMerja Voutilainen
Merja Voutilainen
JLJuha Laurén
Juha Laurén
JPJohan Peränen
Johan Peränen
VLVeli-Matti Leppänen
Veli-Matti Leppänen
MSMart Saarma
Mart Saarma

1 January 2017 in Neurobiology of Disease
Verified
Journal Article
Closed access
CICarlos Ibanez
Carlos Ibanez
Jaan-Olle AndressooJaan-Olle Andressoo
Jaan-Olle Andressoo

13 April 2014 in Cell Reports
Verified
Journal Article
Open access
MLMaria Lindahl
Maria Lindahl
TDTatiana Danilova
Tatiana Danilova
EPErik Palm
Erik Palm
PLPäivi Lindholm
Päivi Lindholm
VVVootele Võikar
Vootele Võikar
MSMart Saarma
Mart Saarma
All forms of diabetes mellitus (DM) are characterized by the loss of functional pancreatic β cell mass, leading to insufficient insulin secretion. Thus, identification of novel approaches to protect and restore β cells is essential for the development of DM therapies. Mesencephalic astrocyte-derived neurotrophic factor (MANF) is an endoplasmic reticulum (ER)-stress-inducible protein, but its physiological role in mammals has remained obscure. We generated MANF-deficient mice that strikingly develop severe diabetes due to progressive postnatal reduction of β cell mass, caused by decreased proliferation and increased apoptosis. Additionally, we show that lack of MANF in vivo in mouse leads to chronic unfolded protein response (UPR) activation in pancreatic islets. Importantly, MANF protein enhanced β cell proliferation in vitro and overexpression of MANF in the pancreas of diabetic mice enhanced β cell regeneration. We demonstrate that MANF specifically promotes β cell proliferation and survival, thereby constituting a therapeutic candidate for β cell protection and regeneration.

1 October 2008 in Molecular and Cellular Neuroscience
Verified
Journal Article
Closed access
PLPäivi Lindholm
Päivi Lindholm
JPJohan Peränen
Johan Peränen
Jaan-Olle AndressooJaan-Olle Andressoo
Jaan-Olle Andressoo
NKNisse Kalkkinen
Nisse Kalkkinen
Zaal KokaiaZaal Kokaia
Zaal Kokaia
MSMart Saarma
Mart Saarma

8 May 2014 in Cellular and Molecular Life Sciences
Verified
Journal Article
Open access
PDF file
KVKärt Varendi
Kärt Varendi
AKAnmol Kumar
Anmol Kumar
MHMari-Anne Härma
Mari-Anne Härma
Jaan-Olle AndressooJaan-Olle Andressoo
Jaan-Olle Andressoo
Brain-derived neurotrophic factor (BDNF) is a secreted protein of the neurotrophin family that regulates brain development, synaptogenesis, memory and learning, as well as development of peripheral organs, such as angiogenesis in the heart and postnatal growth and repair of skeletal muscle. However, while precise regulation of BDNF levels is an important determinant in defining the biological outcome, the role of microRNAs (miRs) in modulating BDNF expression has not been extensively analyzed. Using in silico approaches, reporter systems, and analysis of endogenous BDNF, we show that miR-1, miR-10b, miR-155, and miR-191 directly repress BDNF through binding to their predicted sites in BDNF 3′UTR. We find that the overexpression of miR-1 and miR-10b suppresses endogenous BDNF protein levels and that silencing endogenous miR-10b increases BDNF mRNA and protein levels. Furthermore, we show that miR-1/206 binding sites within BDNF 3′UTR are used in differentiated myotubes but not in undifferentiated myoblasts. Finally, our data from two cell lines suggest that endogenous miR-1/206 and miR-10 family miRs act cooperatively in suppressing BDNF through their predicted sites in BDNF 3′UTR. In conclusion, our results highlight miR-1, miR-10b, miR-155, and miR-191 as novel regulators of BDNF long and short 3′UTR isoforms, supporting future research in different physiological and pathological contexts.